Photo of Doug LaMalfa
R United States House · District 1 · California

Rep. Doug LaMalfa

Compare
Total votes
2,525
all sessions
Attendance
94%
148 missed
Lower than 84% of chamber peers
With party
94%
of cast votes
Higher than 84% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Lower than 92% of chamber peers
Sponsored
1,204
bills & resolutions
Near the chamber average
Committees
0
assignments
1,204 bills and resolutions

Sponsored bills

Total
1,204
Primary
53
Co-sponsor
1,151
This page
1,204
matching current filters
Primary HR 5821
In committee · United States House · Lead sponsor
Rural Hospital Fairness Act

Maddy summaryHR 5821, the Rural Hospital Fairness Act, preserves Medicare critical access hospital (CAH) status for specific rural facilities that lost certification due to location changes. It directly affects hospitals designated as CAHs before 2002, certified as of December 31, 2024, and located in counties with no other hospitals at the time of their certification loss. The bill's key provision "deems" these facilities as still certified under Medicare, allowing them to maintain eligibility for CAH funding despite not meeting the standard location requirement. This change prevents certain rural hospitals from losing vital Medicare reimbursement due to geographic shifts in their service area. The policy change applies only to qualifying facilities meeting all other CAH criteria.

In committee Oct 24, 2025 0 co-sponsors
Co-sponsor HRES 803
In committee · United States House · Co-sponsor
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Maddy summaryHRES 803 is a non-binding resolution urging the FDA to reassess the safety of all chemical abortion drugs based on recent independent studies. It specifically requests the FDA reevaluate safety data and publicly release a full safety review including real-world complications. The resolution does not change laws or create new requirements but asks the FDA to consider findings that claim complication rates are 22 times higher than current reports. This resolution directly addresses the FDA's regulatory oversight of these drugs, not other entities or policies.

In committee Oct 10, 2025 1 co-sponsor
Co-sponsor HR 5728
In committee · United States House · Co-sponsor
Rural Homeownership Continuity Act of 2025

Maddy summaryThis bill modifies the USDA's 502 housing loan program to make it easier for rural homeowners to transfer properties with existing loans. It allows qualified buyers to assume a guaranteed loan when purchasing a property, releasing the original borrower from liability and transferring the loan's obligations to the new owner. The changes apply to loans guaranteed under the program after the bill's enactment, directly affecting rural homeowners and buyers in USDA loan programs. The bill also permits servicers to charge fees for transaction costs related to these loan assumptions.

In committee Oct 10, 2025 1 co-sponsor
Co-sponsor HRES 789
In committee · United States House · Co-sponsor
Expressing support for the recognition of Christopher Columbus and his impact on the Italian-American community, and recognizing the second Monday in October as "Columbus Day".

Maddy summaryThis resolution (HRES 789) expresses the U.S. House of Representatives' support for observing the second Monday in October as "Columbus Day," recognizing Christopher Columbus's historical role and his significance to the Italian-American community. It does not create new law or policy but affirms the existing national observance of the holiday. The resolution was introduced by Rep. Garbarino and 10 co-sponsors in October 2025. It honors Columbus's legacy as connected to Italian-American contributions, without altering current federal holiday status.

In committee Oct 6, 2025 1 co-sponsor
Co-sponsor HR 842
In committee · United States House · Co-sponsor
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HR 38
In committee · United States House · Co-sponsor
Constitutional Concealed Carry Reciprocity Act of 2025

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).

In committee Oct 3, 2025 1 co-sponsor
Co-sponsor HR 5646
In committee · United States House · Co-sponsor
Restoring Safeguards for Dangerous Abortion Drugs Act

Maddy summaryThis bill requires the FDA to reinstate the 2011 safety program for mifepristone (the drug sold as Mifeprex) and bans its importation into the U.S. It creates federal liability for harm caused by illegal importers of the drug, allowing lawsuits for bodily injury or mental health harm resulting from unauthorized importation. The law applies specifically to telehealth providers, pharmacies, or others who knowingly import mifepristone across state lines. It takes effect 90 days after enactment.

In committee Sep 30, 2025 1 co-sponsor
Co-sponsor HRES 719
Passed · United States House · Co-sponsor
Honoring the life and legacy of Charles Charlie James Kirk.

Maddy summaryHRES 719 is a House resolution honoring Charles "Charlie" James Kirk, the founder of Turning Point USA who was assassinated on September 10, 2025. The resolution condemns his assassination and all political violence, extends condolences to his family, and calls on Americans to reject violence while promoting civil discourse. It specifically recognizes Kirk's legacy as a defender of constitutional principles and his role in inspiring youth through free speech and faith-based civic engagement. As a commemorative resolution, it does not enact policy changes but formally expresses the House's stance on honoring his life and legacy.

Passed Sep 19, 2025 1 co-sponsor
Co-sponsor HR 5485
In committee · United States House · Co-sponsor
Second Chance at Life Act of 2025

Maddy summaryThis federal bill requires abortion providers to inform patients about potential reversal of mifepristone-based chemical abortions (the two-drug process) at least 24 hours before the procedure. After the first drug is dispensed, providers must give written instructions stating that reversal may be possible if the second pill hasn't been taken. Facilities must post visible signs about reversal options, and the government must maintain a website with reversal resources. Violations allow affected patients or family members to sue for damages.

In committee Sep 18, 2025 1 co-sponsor
Co-sponsor HR 5483
In committee · United States House · Co-sponsor
Chloe Cole Act

Maddy summaryHR 5483, the Chloe Cole Act, prohibits health care professionals, hospitals, or clinics from providing certain gender-affirming treatments to minors under 18 that aim to alter their body to align with a gender identity different from their sex assigned at birth. This includes puberty blockers, sex hormones, and specific surgeries, unless the treatment falls under narrow exceptions like medically necessary care for disorders of sexual development, injuries, or detransition. The bill creates a private right for affected minors or their guardians to sue providers for damages in federal court, with strict liability for violations. It applies when interstate commerce is involved (e.g., payments, travel, communications) and sets a 25-year statute of limitations from the minor’s 18th birthday.

In committee Sep 18, 2025 1 co-sponsor
Showing 61 to 70 of 1,204 bills
Previous 1 … 6 7 8 … 121 Next